Epitope-based assay to determine the efficiency of cleavage by HIV-1 protease

被引:5
作者
Serio, D
Weber, IT
Harrison, RW
Louis, JM
Srinivasan, A
机构
[1] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Inst Biotechnol & Med, Philadelphia, PA 19107 USA
关键词
D O I
10.2144/99262bm13
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:242 / +
页数:3
相关论文
共 7 条
[1]  
Chubet RG, 1996, BIOTECHNIQUES, V20, P136
[2]  
KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025
[3]   AN ACTIVE-SITE MUTATION IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE (PR) CAUSES REDUCED PR ACTIVITY AND LOSS OF PR-MEDIATED CYTOTOXICITY WITHOUT APPARENT EFFECT ON VIRUS MATURATION AND INFECTIVITY [J].
KONVALINKA, J ;
LITTERST, MA ;
WELKER, R ;
KOTTLER, H ;
RIPPMANN, F ;
HEUSER, AM ;
KRAUSSLICH, HG .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7180-7186
[4]   AUTOPROCESSING OF THE HIV-1 PROTEASE USING PURIFIED WILD-TYPE AND MUTATED FUSION PROTEINS EXPRESSED AT HIGH-LEVELS IN ESCHERICHIA-COLI [J].
LOUIS, JM ;
MCDONALD, RA ;
NASHED, NT ;
WONDRAK, EM ;
JERINA, DM ;
OROSZLAN, S ;
MORA, PT .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 199 (02) :361-369
[5]  
MELLORS JW, 1996, NAT MED, V5, P490
[6]   Development of a novel anti-HIV-1 agent from within: Effect of chimeric Vpr-containing protease cleavage site residues on virus replication [J].
Serio, D ;
Rizvi, TA ;
Cartas, M ;
Kalyanaraman, VS ;
Weber, IT ;
Koprowski, H ;
Srinivasan, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3346-3351
[7]  
TOZER J, 1991, FEBS LETT, V281, P77